Somnigroup International Inc. SGI 深 沪
已收盘 02-06 16:00:00 美东时间
96.32
+1.480
+1.56%
华盛通- 最 高96.815
- 今 开95.50
- 成交量 360.23万股
- 最 低 93.8822
- 昨 收 94.84
- 总市值 202.18亿
- 52周最高 96.815
- 市盈率 静 --
- 换手率 1.72%
- 52周最低 53.10
- 委 比 6.67%
- 总股本 2.10亿
- 历史最高 103.41
- 量 比 1.87
- 振 幅 3.09%
- 历史最低 20.03
- 每 手 1
- 风险率 12.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Somnigroup International veranstaltet Investorentag an der New Yorker Börse
Somnigroup International veranstaltet Investorentag an der New Yorker Börse Somnigroup International Inc. wird am 4. März 2026 einen Investorentag an der New Yorker Börse sowie per Live-Webcast ausrichten. Das Management präsentiert dabei die strategische Ausrichtung und Wachstumspläne des Unternehm
02-05 19:55
Somnigroup International Hosts Investor Day at New York Stock Exchange
Somnigroup International Hosts Investor Day at New York Stock Exchange Somnigroup International Inc. will host an Investor Day on March 4, 2026, at the New York Stock Exchange and via live webcast. The event will feature presentations from executive management discussing the company's strategic visi
02-05 19:55
Somnigroup to Host Investor Day on March 4, 2026
- Executive Leadership to Discuss Strategic Vision and Growth Opportunities DALLAS, Feb. 5, 2026 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI, "Company" or "Somnigroup") will ho...
02-05 19:55
Somnigroup to Engage in Discussions with Leggett & Platt
DALLAS, Jan. 20, 2026 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI, "Somnigroup") today issued the following statement in response to the announcement by Leggett & Platt Inc. (NY...
01-20 19:31
Somnigroup International Proposes All-Stock Acquisition Of Leggett & Platt Valued At $12/Shr
Proposal represents 30.3% premium to the average closing price of Leggett & Platt's shares during the last 30 trading daysCombination would provide Leggett & Platt shareholders with significant premium and
2025-12-01 19:35
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Somnigroup International Unveils Strategic Initiatives Update
Somnigroup International ( ($SGI) ) just unveiled an update. On November 6, 202...
2025-11-07 05:54
